Drug Shortage Report for APO-GABAPENTIN

Last updated on 2022-01-21 History
Report ID 152310
Drug Identification Number 02244305
Brand name APO-GABAPENTIN
Common or Proper name GABAPENTIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-03
Estimated end date 2022-02-04
Actual end date
Shortage status Actual shortage
Updated date 2022-01-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-01-21 French Compare
v5 2022-01-21 English Compare
v4 2022-01-14 French Compare
v3 2022-01-14 English Compare
v2 2022-01-07 French Compare
v1 2022-01-07 English Compare

Showing 1 to 6 of 6